Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease

Tau protein as a diagnostic and prognostic biomarker in Amyotrophic Lateral Sclerosis

(2021) Luisa Agnello et al.   EUROPEAN JOURNAL OF NEUROLOGY

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis

(2021) Tiziana Colletti et al.   Brain Sciences

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease

(2021) Yulan Fan et al.   Frontiers in Aging Neuroscience

Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia

(2021) Eline A.J. Willemse et al.   NEUROBIOLOGY OF AGING

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease

(2020) Martí Colom-Cadena et al.   Alzheimers Research & Therapy

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease

(2020) Mei Xue et al.   Aging-US

Biochemical Markers in Alzheimer’s Disease

(2020) Alessandro Rabbito et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis

(2020) Luisa Agnello et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Neurogranin as a Novel Biomarker in Alzheimer’s Disease

(2020) Luisa Agnello et al.   Labmedicine

Neurogranin: A Potential Biomarker of Neurological and Mental Diseases

(2020) Yang Xiang et al.   Frontiers in Aging Neuroscience

Establishing the 99th percentile for high sensitivity cardiac troponin I in healthy blood donors from Southern Italy

(2019) Luisa Agnello et al.   Biochemia Medica

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

(2018) Erik Portelius et al.   ACTA NEUROPATHOLOGICA

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration

(2017) Anthony Brureau et al.   NEUROBIOLOGY OF DISEASE

Recommendation for the review of biological reference intervals in medical laboratories

(2016) Joseph Henny et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

(2016) Niklas Mattsson et al.   EMBO Molecular Medicine

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

(2016) Mehtap Bacioglu et al.   NEURON

Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease

(2016) Rawan Tarawneh et al.   JAMA Neurology

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease

(2015) Erik Portelius et al.   BRAIN

Neurogranin in the CSF signals early Alzheimer disease and predicts disease progression

(2015) Ian Fyfe   Nature Reviews Neurology

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

(2015) Konstantin Hellwig et al.   Alzheimers Research & Therapy

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

(2015) Maartje I. Kester et al.   JAMA Neurology

Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update

(2012) Marta del Campo et al.   Biomarkers in Medicine

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Neurogranin enhances synaptic strength through its interaction with calmodulin

(2009) Ling Zhong et al.   EMBO JOURNAL

Long-term potentiation: two pathways meet at neurogranin

(2009) Yasunori Hayashi   EMBO JOURNAL